Allergy sufferers breathing easier, FDA approves first ‘ouchless’ alternative to allergy shots

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

The Food and Drug Administration has approved the first under-the-tongue allergy treatment, a welcome alternative for patients who get regular allergy shots.

The pill is a mixture of grass pollen extracts compressed into a tablet that rapidly dissolves.

Patients who have tried the drug reported a drastic reduction in their allergy symptoms and medication use.

The treatment slowly builds a patient’s tolerance to grass pollen, something that used to be accomplished with routine allergy shots.

Experts said patients will take their first dose of Oralair in a doctor’s office to ensure they don’t have a serious reaction and then can take the rest at home.

The pill will be available by prescription only.

MORE: Get more information on Oralair from the FDA


Follow @KFOR on Twitter